FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023320286> ?p ?o ?g. }

• W2023320286 endingPage "1524" @default.
• W2023320286 startingPage "1514" @default.
• W2023320286 abstract "Undifferentiated endometrial carcinomas are very aggressive high-grade endometrial carcinomas that are frequently under-recognized. This study aimed to analyze the molecular alterations underlying the development of these endometrial carcinomas, focusing on those related to dedifferentiation. We assessed a series of 120 tumors: 57 grade 1 and 2 endometrioid endometrial carcinomas, 15 grade 3 endometrioid endometrial carcinomas, 27 endometrial serous carcinomas, and 21 undifferentiated endometrial carcinomas. We found a high frequency of DNA mismatch repair deficiency (38%) and moderate rate of p53 overexpression (∼33%) in undifferentiated carcinomas. In contrast to the characteristic endometrioid phenotype, there was a dramatic downregulation of E-cadherin expression in the undifferentiated subtype. Quantitative methylation studies dismissed CDH1 promoter hypermethylation as the mechanism responsible for this change in gene expression, while immunohistochemistry revealed that the E-cadherin repressor ZEB1 was frequently overexpressed (62%) in undifferentiated endometrial carcinomas. This finding was accompanied by a sharp downregulation in the expression of the miR-200 family of microRNAs, well-known targets of ZEB1. Furthermore, there was enhanced expression of epithelial-to-mesenchymal transition markers in undifferentiated endometrial carcinomas, such as N-cadherin, cytoplasmic p120, and osteonectin. In addition, HMGA2, a regulator of epithelial-to-mesenchymal transition that is expressed in aggressive endometrial tumors, such as endometrial serous carcinomas and carcinosarcomas, was expressed in >20% of undifferentiated carcinomas. These results suggest that ZEB1 overexpression, associated with E-cadherin and miR-200s downregulation, and the expression of mesenchymal markers might enhance the metastatic potential of undifferentiated endometrial carcinomas, leading to a poor prognosis. In addition, our observations suggest that the immnohistochemical analysis of E-cadherin and ZEB1 can aid in the differential diagnosis of the more agressive undifferentiated endometrial carcinomas from grade 3 endometrioid carcinomas." @default.
• W2023320286 created "2016-06-24" @default.
• W2023320286 creator A5030186033 @default.
• W2023320286 creator A5040432994 @default.
• W2023320286 creator A5052359409 @default.
• W2023320286 creator A5052379741 @default.
• W2023320286 creator A5053542215 @default.
• W2023320286 creator A5057016137 @default.
• W2023320286 creator A5063095927 @default.
• W2023320286 creator A5067027420 @default.
• W2023320286 creator A5069925431 @default.
• W2023320286 creator A5072246660 @default.
• W2023320286 creator A5090159813 @default.
• W2023320286 date "2013-06-07" @default.
• W2023320286 modified "2023-10-17" @default.
• W2023320286 title "ZEB1 overexpression associated with E-cadherin and microRNA-200 downregulation is characteristic of undifferentiated endometrial carcinoma" @default.
• W2023320286 cites W1492264720 @default.
• W2023320286 cites W1791425304 @default.
• W2023320286 cites W1966241991 @default.
• W2023320286 cites W1971303929 @default.
• W2023320286 cites W1971624340 @default.
• W2023320286 cites W1974254016 @default.
• W2023320286 cites W1976324983 @default.
• W2023320286 cites W1986578434 @default.
• W2023320286 cites W1997023156 @default.
• W2023320286 cites W2013008781 @default.
• W2023320286 cites W2014192402 @default.
• W2023320286 cites W2019294425 @default.
• W2023320286 cites W2019940629 @default.
• W2023320286 cites W2020613407 @default.
• W2023320286 cites W2024598861 @default.
• W2023320286 cites W2025647419 @default.
• W2023320286 cites W2035436774 @default.
• W2023320286 cites W2046811050 @default.
• W2023320286 cites W2066441178 @default.
• W2023320286 cites W2076868907 @default.
• W2023320286 cites W2078993783 @default.
• W2023320286 cites W2094674030 @default.
• W2023320286 cites W2101136328 @default.
• W2023320286 cites W2107462637 @default.
• W2023320286 cites W2110937119 @default.
• W2023320286 cites W2112666597 @default.
• W2023320286 cites W2124022855 @default.
• W2023320286 cites W2125120607 @default.
• W2023320286 cites W2142982924 @default.
• W2023320286 cites W2147807172 @default.
• W2023320286 cites W2155131748 @default.
• W2023320286 cites W2156734818 @default.
• W2023320286 cites W2319829547 @default.
• W2023320286 cites W2326889571 @default.
• W2023320286 doi "https://doi.org/10.1038/modpathol.2013.93" @default.
• W2023320286 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23743934" @default.
• W2023320286 hasPublicationYear "2013" @default.
• W2023320286 type Work @default.
• W2023320286 sameAs 2023320286 @default.
• W2023320286 citedByCount "64" @default.
• W2023320286 countsByYear W20233202862014 @default.
• W2023320286 countsByYear W20233202862015 @default.
• W2023320286 countsByYear W20233202862016 @default.
• W2023320286 countsByYear W20233202862017 @default.
• W2023320286 countsByYear W20233202862018 @default.
• W2023320286 countsByYear W20233202862019 @default.
• W2023320286 countsByYear W20233202862020 @default.
• W2023320286 countsByYear W20233202862021 @default.
• W2023320286 countsByYear W20233202862022 @default.
• W2023320286 countsByYear W20233202862023 @default.
• W2023320286 crossrefType "journal-article" @default.
• W2023320286 hasAuthorship W2023320286A5030186033 @default.
• W2023320286 hasAuthorship W2023320286A5040432994 @default.
• W2023320286 hasAuthorship W2023320286A5052359409 @default.
• W2023320286 hasAuthorship W2023320286A5052379741 @default.
• W2023320286 hasAuthorship W2023320286A5053542215 @default.
• W2023320286 hasAuthorship W2023320286A5057016137 @default.
• W2023320286 hasAuthorship W2023320286A5063095927 @default.
• W2023320286 hasAuthorship W2023320286A5067027420 @default.
• W2023320286 hasAuthorship W2023320286A5069925431 @default.
• W2023320286 hasAuthorship W2023320286A5072246660 @default.
• W2023320286 hasAuthorship W2023320286A5090159813 @default.
• W2023320286 hasBestOaLocation W20233202861 @default.
• W2023320286 hasConcept C104317684 @default.
• W2023320286 hasConcept C121608353 @default.
• W2023320286 hasConcept C126322002 @default.
• W2023320286 hasConcept C127561419 @default.
• W2023320286 hasConcept C131075544 @default.
• W2023320286 hasConcept C142724271 @default.
• W2023320286 hasConcept C150173356 @default.
• W2023320286 hasConcept C150194340 @default.
• W2023320286 hasConcept C160160445 @default.
• W2023320286 hasConcept C181199279 @default.
• W2023320286 hasConcept C190727270 @default.
• W2023320286 hasConcept C204232928 @default.
• W2023320286 hasConcept C2777088508 @default.
• W2023320286 hasConcept C2777546739 @default.
• W2023320286 hasConcept C2781460891 @default.
• W2023320286 hasConcept C502942594 @default.
• W2023320286 hasConcept C55493867 @default.
• W2023320286 hasConcept C71924100 @default.
• W2023320286 hasConcept C76419328 @default.

• next